These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2648537)

  • 1. Epidemiology of toxic shock syndrome in the United States: overview.
    Broome CV
    Rev Infect Dis; 1989; 11 Suppl 1():S14-21. PubMed ID: 2648537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic-shock syndrome, United States, 1970-1982.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Apr; 31(16):201-4. PubMed ID: 6804780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonmenstrual toxic shock syndrome associated with barrier contraceptives: report of a case-control study.
    Schwartz B; Gaventa S; Broome CV; Reingold AL; Hightower AW; Perlman JA; Wolf PH
    Rev Infect Dis; 1989; 11 Suppl 1():S43-8; discussion S48-9. PubMed ID: 2928652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update through 1985 on the incidence of toxic shock syndrome among members of a prepaid health plan.
    Petitti DB; Reingold AL
    Rev Infect Dis; 1989; 11 Suppl 1():S22-6; discussion S26-7. PubMed ID: 2928640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for menstrual toxic shock syndrome: results of a multistate case-control study.
    Reingold AL; Broome CV; Gaventa S; Hightower AW
    Rev Infect Dis; 1989; 11 Suppl 1():S35-41; discussion S41-2. PubMed ID: 2928651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic-shock syndrome and the vaginal contraceptive sponge.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Feb; 33(4):43-4, 49. PubMed ID: 6318070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active surveillance for toxic shock syndrome in the United States, 1986.
    Gaventa S; Reingold AL; Hightower AW; Broome CV; Schwartz B; Hoppe C; Harwell J; Lefkowitz LK; Makintubee S; Cundiff DR
    Rev Infect Dis; 1989; 11 Suppl 1():S28-34. PubMed ID: 2928646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative vaginal microflora in women convalescent from toxic shock syndrome and in healthy controls.
    Chow AW; Bartlett KH; Goldring AM
    Infect Immun; 1984 Jun; 44(3):650-2. PubMed ID: 6724691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic shock syndrome: an opportunity for nursing intervention.
    Creehan PA
    J Obstet Gynecol Neonatal Nurs; 1995; 24(6):557-61. PubMed ID: 7562139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic shock syndrome in Canada.
    Clayton AJ; Peacocke JE; Ewan PE
    Can Med Assoc J; 1982 Apr; 126(7):776-9. PubMed ID: 7042059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonmenstrual toxic shock syndrome. Methodologic problems in estimating incidence and delineating risk factors.
    Petitti D; D'Agostino RB; Oldman MJ
    J Reprod Med; 1987 Jan; 32(1):10-6. PubMed ID: 3560058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of tampon characteristics to menstrual toxic shock syndrome.
    Berkley SF; Hightower AW; Broome CV; Reingold AL
    JAMA; 1987 Aug; 258(7):917-20. PubMed ID: 3613021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of publicity on the reporting of toxic-shock syndrome in Wisconsin.
    Davis JP; Vergeront JM
    J Infect Dis; 1982 Apr; 145(4):449-57. PubMed ID: 7069225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic-shock syndrome: tampons, toxins, and time: the evolution of understanding an illness.
    Helgerson SD
    Women Health; 1981; 6(3-4):93-104. PubMed ID: 6306933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.
    Shands KN; Schmid GP; Dan BB; Blum D; Guidotti RJ; Hargrett NT; Anderson RL; Hill DL; Broome CV; Band JD; Fraser DW
    N Engl J Med; 1980 Dec; 303(25):1436-42. PubMed ID: 7432402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic-shock syndrome not associated with menstruation. A review of 54 cases.
    Reingold AL; Dan BB; Shands KN; Broome CV
    Lancet; 1982 Jan; 1(8262):1-4. PubMed ID: 6119410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contraception and toxic-shock syndrome: a reanalysis.
    Shelton JD; Higgins JE
    Contraception; 1981 Dec; 24(6):631-4. PubMed ID: 7326935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal tampon model for toxic shock syndrome.
    Melish ME; Murata S; Fukunaga C; Frogner K; McKissick C
    Rev Infect Dis; 1989; 11 Suppl 1():S238-46; discussion S246-7. PubMed ID: 2928642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic-shock syndrome in Minnesota: results of an active-passive surveillance system.
    Osterholm MT; Forfang JC
    J Infect Dis; 1982 Apr; 145(4):458-64. PubMed ID: 7069226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic shock and tampons. Evaluation of the epidemiologic evidence.
    Harvey M; Horwitz RI; Feinstein AR
    JAMA; 1982 Aug; 248(7):840-6. PubMed ID: 7047782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.